 Good afternoon or good evening in function of where you're based Hello everyone, and thank you in name of the European young Milano patient group and MP Milano patient Europe very very hard welcome welcome to you all and Thanks to you spend 60 minutes with us for this big launch the launch of our official launch of our group and So before we are starting the meeting and I if you could please share The slides I would love to give you a couple of housekeeping housekeeping Elements my name is Vincent close and I'm based in Belgium, but I will introduce myself a little bit later together with the rest of the team And you can please put the next slides If you're all okay, we'll record this this meeting just to be sure that some of our Patients could potentially replay the meeting if they are not able to join So if you don't want to be Recognized if you want to stay anonymous, please Let's say switch your camera and maybe just change your name if you want don't want to have your name on the on the screen We will Yeah, ask you to Mute your microphone just to be sure that there are no disturbances during the the presentation But of course, and I hope you will all have a lot of questions So there's a chat. There's a Q&A and there will be a Q&A session after the the presentation So please make it as interactive possible and and ask a question in the in the Q&A box If you have any technical issue to hear to see something Don't be shy and and raise your hand. So there is a little hand at the bottom of the the zoom The zoom Element and then you can you will be will be in touch with one of our people to help you to help you there So I should say Let's start and let's kick off Anna To give you an idea on the agenda, but normally you will you have received the agenda as well by mail, but I will I will launch Officially the introduction of of our our meeting We will introduce ourselves. Who is the group behind? EYMG and then we will have you you will be able to have a little bit An insight about who is my on a patient Europe MP I will give the word to Katie and Kate for that one And afterwards. Yeah, we will present you what the goals are of our group What are what you can expect from us and how we will together make it? a better Better step-by-step elements for for the younger patients of of myeloma Afterwards, we will have a Q&A so again, don't be shy and ask the questions every question you should have and We will try to to answer that we'll close around 6 p.m We will promise you what respect your timing because we know that it's important that that we can respect that Yeah, Anna Um behind the core team we are patients or we are patient carers and I will leave the words One by one to my fellow colleagues So Lara, please Could you introduce yourself? Hello everyone I'm so pleased to to be here and see such a strong participation in this working group. I'm Lara I'm from Portugal. I'm the executive director of Portuguese Association against leukemia And I really believe that we can be highly effective I'll be effective by the form for young patients with multiple myeloma. So welcome everyone Hi, good afternoon to you all. My name is Philippa Lopes. I'm 32 years old and I live in Lisbon, Portugal So a little bit about me. My academic background is in the field of science and recently I specialized in clinical trials I'm also a patient. I was diagnosed with multiple myeloma in March 2021 when I was just 29 years old last year I became a by became a volunteer for the Portuguese Association against leukemia and attended the MP Advocate the development program which allowed me to be involved in several projects related to multiple myeloma For me, it's an honor to be part of the discord team of this support group And I hope I can be helpful in any way. Thank you all Thank you, Philippa. Linda Hello everyone, welcome to the launch event. My name is Linda So I work as a project manager in our member and patient community programs at MPE So it's a pleasure to work along with the core team And to help them in the work that they're doing and it's nice to see you all Welcome. Thank you Thank you Linda and I'm Vincent. I'm based in Belgium. I'm a myeloma patient been diagnosed in 2019 At the age of 48 And I think that's the colleagues definitely said the right things and for sure Jay Pointed out the reason why we find it so important to you to have a specific support for your patients So I'm your main host today And let's let's go and next Good leave me allow me to to give the words to Katie and Kate to present you Who is MPE basically Thanks Vince. Hi everyone. I'm Katie Joyner. I'm a co-CEO at myeloma patients Europe I've been at MPE for the last four years I'm originally from the United States, but I live in Munich and we are so excited to Officially launch this group today. We're so grateful for the time and dedication and efforts of the core team and Linda for bringing this forward MPE really wants to make sure that we're supporting the needs of all myeloma patients and after Speaking with the core group for I think now maybe several months almost a year about this It was really clear that there was a distinct need for something like this in Europe And we're so glad to be able to bring that to fruition today So I'll just give you a brief overview for an of MPE for those who aren't familiar with us next slide. Thanks So MPE started in 2011. So we're about 13 years old We started as a very small volunteer run organization and slowly over time have become a professional and Multidisciplinary international team and our mission is really to provide education and information and support to our members So we're a member organization and to make sure that The national organizations that we work with have the tools and resources They need to advocate effectively and to support patients every day in the work and the in their lives and living with myeloma and aeloma Dosis and we also represent patient needs at a European level with stakeholders like pharmaceutical companies, payers, industry Clinicians, but it's really that work that we do with the national organizations to make make sure that Patients are getting the the tools and resources and care that they need on a daily basis. Next slide So here's a map of our current members right now We have 49 members representing 31 countries in Europe at a few further field including Armenia and Turkey and Israel as well as Canada and in countries where we don't yet have a member we work with the local patient population or the local clinical community to make sure that we're still Raising the voices and experiences of those patients at a European level next slide Here's a picture of our board. We have seven board members And our board is made up of myeloma patients Cares and patient advocates from Germany, Finland, Israel, Norway, Sweden and Poland Most of our board is connected also to the national patient community So they really bring the perspectives and needs of Their national organizations to the work that MPE does. Next slide And here is a picture of our team so we now have 13 team members with the recent addition of Monica in our access and policy work stream and We we represent Several work streams that Kate will go into a bit about the work that we do but we're an international team and I think we're really dedicated to working with our members and supporting The patient community and what they need and so if you need anything you can always reach out to Any member of the team and hopefully you'll get to know us in the various projects and programs that that we operate and that you might get further involved in Next slide And now I'll turn it over to Kate to talk a bit about our programs Great. Thank you, Katie. And so hi everyone. My name is Kate Morgan and I'm the other co-chief executive here at MPE I've worked here for about six years now and take a big lead on the work that we do on access and diagnosis and treatment and care and We're really pleased to be launching This program today is and the provision of information the support for younger patients is a huge area of unmet need I mean if you have any Questions or feedback for the team after this and please let us know and I'll just talk you through and a few of our core programs and before handing back to Vince But firstly, I just wanted to tell you about our access policy and regulatory programs So as an organization and we really aim to make sure that patients have access to the best treatment and care across Europe And also represent their interests at a national level as well as European And we really do that through evidence generation So we have a program called the Miloam access at this where we we try and map access To new drugs in Miloam and really advocate the reduction of inequalities across Europe And we do a lot of work with policymakers of to European level and we aim to support our members in doing the same at a national level too And and we we have a program specifically the Central Eastern European members Where we we aim to identify and address some of the core challenges faced and within the region And because we know there are specific access issues with trials in medicines and next slide please in terms of The next pillar of our work is the medical education and scientific engagement and through this we really aim to promote scientific progress to address the greatest unmet needs in Miloam We also aim to educate and inform our members and also Miloam of patients and their families about the latest developments in Miloam in access to clinical trials A core program that will be launching in the coming months is the Miloam in amyloidosis clinical trial navigator which Will be an online platform and sort of searchable tool for patients to see what trials are available in their countries and also what trials are available across Europe And so you should keep an eye out that on our on our website and through our social media channels as well Other and core programs under this pillar of our work are educational resources and so we have Written fact sheets for the patients and carers on and that the newest treatments in Miloam and we also aim to update on the The big conferences that we attend like the European Hematology Association and the American Society of Hematology And also a big campaign that we're running at the minute is around raising awareness of Miloam and also of al amyloidosis with GPs to make sure that they know What the signs are and and also the tests that they should be conducting if they suspect someone has Miloam and amyloidosis as well and because it's really important and it's a lot of feedback we get from patients That they experience and quite lengthy delays before being diagnosed So if you're if you're interested in hearing more about that and ask a member of staff or look at our website Next slide please Another important aspect of our work is patient evidence and through this department We really aim to identify The biggest unmet needs for Miloam and patients and to inform And sort of data-driven decision-making and by MPE And by external stakeholders and such as regulators and industry as well We do this through generating evidence on patient needs and preferences An example is Last year we ran a huge survey which involved over 600 patients on early diagnosis Where we have we have some really robust data on the pathways to diagnosis for patients In their experience, which we use with with a range of different stakeholders And we recently did a study on an MRD in Miloam and patient in healthcare professional perspectives on where we are on that In Europe and finally, we have a number of ongoing surveys Which you'll hear a lot about Around administration preferences in Miloam And so where do patients want to receive their treatments and how? And and that's an ongoing survey available in a range of different languages that if you're interested in participating And you can see on our website as well And we're also Currently trying to map patient perspectives on a shared decision-making and kind of what that involves in how that should look for Miloam and patients Next slide please And finally and importantly, we have member and patient community programs And through this we really aim to build the capacity of the Miloam and amyloidosis advocacy communities And educate and inform Ensure that we we are a strong collaborative community And a core example of that and which has been already been mentioned is the advocate development program where we aim to to educate New advocates who are interested in learning more about how to get involved around clinical development and access to medicines Another example is the the mpe masterclass where all of our members Once a year come together to meet and discuss the latest Developments and topics and themes in Miloam and amyloidosis and make sure we share information and best practice And and finally the scholarship program where we we fund our own members Programmes and initiatives at a national level and finally A date for your calendars is the 27th of september each year Which is european miloam a day where we aim to have a big sort of awareness raising campaign and over the past few years We focused on early diagnosis and so keep an eye out and for that over the coming year And next slide please Okay, and and without further ado, I'll hand back to vince And to to take you through the next slides, but again welcome to the meeting and thank you so much for participating Yeah, thank you katie and and and kate for this explanation and we're very Very grateful that that that mpe is behind us to you to the group in order to to support what we want to To deploy for for for you for as all as as patients So allow me to give you in the next couple of slides some some Tips on on the goals. We want you to reach and share with you were where what what we really want to To deploy for for you all the next slide please Basically And you maybe heard that or read that they We are under the 65 years old Almost 37 of all the miloma patients. So it's it's it's really a minority of all the patients Of miloma and that's exactly one of the important elements that that we want to point out We are in minority, but we need some specific Answers to Questions that we have issues that we have and maybe they're not today Point out like like we would love to to have if we are looking into the age of 50 10% only 10% of the miloma patient are under the 50 year The age of 50 which is which is really really Not not a lot and that's why we want to provide support with our group to you To these you almost miloma patients and she pointed out as well a little bit earlier in in his presentation Hi, please um The reason or the reasons behind the creation of this group Next to the personal experience that we all have in the in the core group Of of missing some some elements, but i've been looking into a couple of of publications and Recently, I mean in in june last year. They have been a publication from from us point out around around the younger miloma patients and I wanted to give you some clear statement that they have been that they have been Giving The number of young male patients is standing to To grow slightly and this is Basically one of the fact that that this number is drawing is due to the fact that we are a little bit early Diagnosed which is basically good. So um as as soon as we can be diagnosed Better it is for us, uh, and and and for a treatment that we can have so These number these 37 percent or 10 percent is likely tending to grow significantly so We have also We see that the the young miloma patients in the literature are underrepresented Definitely, so if we are looking into the different studies that we have available on the web or are In the in the overall literature We see that that we the young patient are underrepresented and this Again an important element for us to say hey, that's that's something that we would like to work on we apparently are Tending to better tolerate treatments and and without or with less discontinuation of the treatment And that's a big difference. That's that that we have with the a little bit older patients or Have a lot of difficulties in in in their treatments as well So of course if we are younger if you're a little bit fitter, uh, we are better in states to uh to to go Under some some treatments and some some heavy treatments. So again, that's that's another important element as well clinical trials important and And Kate pointed out as well clinical trials We have a lot of around multiple miloma as well and specifically for it's it's it's a very good hope for the younger patient as well if if i'm looking at personal experience i'm Under clinical trial and and it's um almost five years that that I have the same treatment. So um, yeah, it's it's it's hopeful if we're looking into uh into all the the clinical trials that are disposal It is definitely something that uh that we would like to To to discuss to point it out as well in the mind of having The same kind of approach for clinical trials across the different countries in europe because we know that it's something Uh a little bit more difficult in eastern and central europe for instance So this is something that's where we would like to uh to to to have uh, uh the support as well And of course It seems that we have we tend to have uh longer and hopefully a better life expectation that that's uh older people So next to the support that we want to give uh to uh to you all to to to as all We would like to see together with mp how we could leverage and and and the power that mp has in terms of lobbying To answer all these questions and trying to have a little bit more spots on the younger uh madama patients uh across europe so Definitely on one side support direct support to you all But as well, uh, how we can uh, how we can lobby and how we can uh, uh make that that we put a little bit more Lights on uh on on the younger Milama patients next slide please What is um your opinion on milama patient group and for sure what is nuts and allow me to start with what we are nuts Definitely were not uh an alternative for your patient group, uh where you are um, probably, uh, you've been subscribed and kt presented 31 countries where um their uh support group 49 uh different groups in in in the different countries this These groups are the first touch point that you have and hopefully you you you stay in touch with with your group So we don't aim to replace Your local uh in the country your local uh support group Definitely not Once you add an extra dimension to the group and to the local Local community that that that you have to gather with the other milama patient in your country So, um again and I emphasis that this is this is not an alternative for for the group that you are in today Uh, and for sure we have a group representative in in the, uh, you know core group So just to be sure that uh, it's not one or the other, but it's a combination of the two and together will be stronger Um, so again, yeah, we are community of uh of european, uh less than 50 55 years milama patients. Yeah, we had to point an age on that one, but is it 56? Meanwhile within two years, I will be over the 50 years or 55. So, um, we decided to start with only in english forum We hope that we will able to join you all and and to have a conversation in english We we stated that a lot of younger people are able to Manage the the english, uh, english language. We will see in the future, but at the very first stage We will remain to communicate in in english. We uh, we all and uh, hopefully it's uh, it's uh, it's okay for uh for for all of you um Interactive and I pointed out at the very beginning of of this presentation. So don't be shy, please We need the experience as well. So we are not i'm not a professional And and and so are my my fellow colleagues in in the group. We are not professional. So We feel and we know some elements that we think that it will be helpful for you But make it make it interactive ask the question And and and and request maybe some elements that you think they could this could be interesting for uh for the group By the way, I'm coming uh back to you. Um, uh to you, uh our core group We are open to some of you if you want to join the core group and for sure if we're talking about center or eastern europe Be your guest to join the the the core group to uh to help us Pulling this this project together with us. So I forgot to mention that earlier um And we are a team uh work. Um, it was searching for professionals. So you will see we will try to give you on the recent on um every quarter To give you an idea on on on on the subject and and to touch upon a topic And we will try to find each time a professional who could give us A good visibility on on on the problematic on or the issue that you could have So we will try to uh to to work together with the mp. Of course to to find the best professionals to Uh to touch the points that and the the topics that we want you to touch with you all So like I said, we're not say an alternatives. Um, um and we won't be able First, but we don't want to give uh medical advice. This is not a goal This is really not the goal of our group. So I saw a couple of face group Facebook groups where some are um, um posting their uh blood analysis and asking for uh for uh advice We won't do that. So please don't do that in in that forum. Uh, we're not again We're not professional. So we're not aiming to give you uh any advice And I think this is not the right place to do that So if you want to have an advice, please go to your gp or go go to your uh metallurgist Um, this is not the the the right place to uh to give advice Of course, you can share your experience, of course But uh, don't don't ask for advice nor to uh to the team or to your fellow patients in the group And we are of course not a top down Uh, so we are here for you. It's it's it's a very flat organization. So please Share your experience and and and be part of the group uh and and uh and make uh make your voice And and and so that we uh, we are all growing together in in in this group So we are all learning just like I said Next slide please Anna um Having thought with uh with the um with the members of core core group We pointed out a couple of topics that we Thought it could be interesting to uh to touch upon uh at the very first stage But of course this list is not final If I'm looking into the list, I could for instance start with A finance and j pointed out as well We have to pay a house so Finance is is one of the important topics as well But um on top of that we we we have some some very specific Topics that if we're 65 that we absolutely don't have Look for instance at fertility Uh, and of course if we have patients around 2025 30 35 They're thinking about having babies. They're thinking about having children How can we manage that? With uh with the fact that that we're that we are under the disease of myeloma How can we manage that and this is for instance one of the elements that we want to to point it out and to help you with um the communication um Again personal experience Um, I had a little boy of 11 at the point of time How do you manage a communication with with the children with the family? Uh, you you just heard that that that you that you are sick and and it's it's it's it's horrible to hear And you have on top of that to manage Little boys or little girls and and you have to share that experience with with the with the children How do you dare that who do how do you do that? So again, we'll try to find the the best professional to share the best tips and the best tricks to you To engage the communication with with your uh with your children with your family Getting getting question from the family getting question for the children from the colleagues How do you want to uh to manage with that? I think this is quite important About your career about your work having the right balance between Being sick going to treatments, but still having some some ambition in in in your work Uh, uh, you need to work of course So how can we balance that and how can we find the best balance again? I think it's it's it's quite important to to have tips and tricks on on on that one The same for sports very important for us, uh to to stay fit uh at every single stage if possible Of course So what do we have to do in terms of sport? What do we have to do in terms of well-being? Again having the right balance in well-being right mindset so Very very important for us as well the sport and and the well-being Last but not least and again, this is not a final list and it's not All the items that we would like to to share with you, but uh the nutrition Very important as well for us What's what's good? What's less good? How do we uh, do we have to uh to manage that together with the treatment that we have and so on and so forth? so you see this is typically some elements that um, I wouldn't say this is Yeah, I would say this is very very specific for the younger patients and for sure if you are looking at fertility communication career These are topics that we're not talking together with with uh people of of of uh age of 65 70 years yeah, and and you you all know this is our disease is typically a disease of of of older people So we need to touch base these points and the touch base these uh these topics together and having An idea on how we can manage that Yes, Anna, please so um, basically, um, we started in December with uh our group and and we started the sub Sites where you all uh subscribed and and thanks thanks for that And at the same time we launch a facebook page What we see is that uh, you were massively subscribing on on the on the subsite and thanks for that and it means that It means a lot for us because it means that that it's important for you. So, uh, thank you for that. So We we we had a lot of of subscription on the on the subsites But we see that you are not all subscribed on the facebook page. So I would um, I would ask you and It's coming a little bit later in the presentation. Please go onto the facebook page Subscribe yourself on the facebook page and and and share your experience and we can uh, we can have some some interaction there as well today The official kickoff the official starts and the presentation of our group and and and what we stands for So I hope it's it's it's quite clear a little bit clear for you all What what we want you to to reach together with you? So this is it was for us and it is for us a very important day, of course And uh in april, uh, we will start with the first, uh, webinar I will come back a little bit later on that one Yes, Anna, please So, um, how could you help us? Um And if you help us you help you you help yourself, of course, uh, this this is uh, this is this is quite important Just like I said, just like I mentioned Please this is a private facebook facebook group. So we we we make it. It's it's a very close group. So, uh, please Join join us on on facebook. We'll share the The link so, um, please join and and and start the interaction with with your fellow patients and and and your colleagues We will have a poll, uh, at the end of the of this of the session, which is almost finished. We're pretty Much good on time. Um, we will ask you, uh, two votes. So We we we thought it would be great To have your votes and to see what matters the most for you In different topics that that I just summed up a little bit a little bit earlier. So We will touch base all the all the elements in in function of the timing, but We would like you to vote and and to say, hey, this is really for me the the top number one Topic that I would like to uh, uh to touch base and uh in base in function of your vote We will uh, we will have the very first, uh Um Session in april. So stay tuned. We will send you the agenda blocker of of course And uh, so we will have the first session within a couple of months and then every single quarter We will have we started with one once a quarter, but we will see together with you again if you want to have a little bit quicker some some inputs or If you say no, no, let's make it twice a year We will reason and regularly touch base with you to to have your advice and your Your feedback Again, give us some feedback, please Again, we're not, uh, professional. I'm not talking about the the people of npe were professionals, but We are in the in in the group. Uh in the support group. We are not professional. So please give us your your your feedback This is this is for you. We are here for you We're here for us also. It it has to be uh, it has to be positive for you, uh as well Um, like I said, if you want to be part of the team Please uh be our guests. Uh, we um, uh, we are welcoming you of course in the in the in the core group Uh, and and for sure like I said central eastern europe, we know that they're a couple of of extra, uh, let's say, um um That's issues, but but but specific, uh elements there in in in those countries So it would be good to have someone from from the side of of of europe um And if you know some professionals Who could present something in in terms of the topics that we want to touch base with you Please share please share the name. Uh, I mean, uh, we are we are not looking We we have some names, of course We have we have some some network, but you probably have network as well So if you know some professionals who could drive a session for us all Be your guests and and share the name with uh with us also We will be very happy to uh to welcome these uh these professionals to uh to present the session Right, um, so I think yes, uh, now you can Right, so just like I said Stay tuned We will have the uh the first session Somewhere in in april Probably the same kind of timing. So around five five p.m There again, I hope that it's it's it's good for you all if if If it has to be five p.m. Is central europe, of course if it's If it has to be a little bit later just let us know To be sure that that that's that we reach you all I think it's again important that that you can join and and that you can have the information that you that you deserve Yes, um, so We will launch the poll If the next yes, uh, I think you can I don't know Where yeah, we already have votes, but that's that's okay. We we make a test before before the call. So no problem. So, um Grab your phone if possible and With the camera of your phone you can You can scan the They the code that you have there and and the top left of your screen And then you will get to the page of slido and you will be able to vote for your top number one item that you would like us to to to reach with With a professional so and we'll have now let's say Until april to find the best speaker for you in function of of the Of the of the topic that that that you would love to have and again, you see you have there five Um I touch base about finance as well. I think it's it could be important that we add that as on the list as well But again, if you have tips about some topics that you would love to To to touch base with us, uh, please send us and send us an A message and we will be very very happy to to head at this one So we have 12 voters as we speak Linda correct me from we have about 40 people in the call. So yeah, we have 44 on the call, but we only see in words But we can keep the poll active And we can also send the link out via email if people would like to continue to vote great and Maybe it would be a great idea to put the poll on the facebook on the facebook group as well. So Maybe for the people who want to vote afterwards Um I hope you don't have any issue connecting to slido if well, please raise your hand so that we can help you Your vote is important to us. So, um, very important that you uh, you are able to uh To vote as well Meanwhile, uh, linda do we have questions in the? Not yet Not yet. No Maybe someone wants you To take the lead and and ask question or was it Very very clear for for you all Hi, my name is Eva. I'm calling from Germany Hi Eva Hi, and so I'm 45 now is 42 when I was diagnosed with amyloidosis as well so another topic that I'll be interested is the likelihood occurrence of secondary cancers since we seem to be at a Increased risk, um, either through the linalidomate that increases the risk of it or just because of the diagnosis itself Um, there's something that's constantly on the back of my mind Very good point Eva very very good point. Absolutely Thank you for that. There's someone else wants you, um I think there is one One participant that can manage to vote Okay May I? Sure gay, please Um, just to how are you going to communicate with the national organizations? Is this will we have to go on the um on the mpe? Or are you going to keep them aware of what you would like or what you're doing? Uh in in all these countries Katie may I may I leave that that question to you? Sure, so gay is the question how kind of how this works with mpe Basically Yes, I mean, I mean when there's something because you know, we are well We try to of course to aware to make it aware to everyone within our members to our members but um I just wanted to know how are you going to communicate with us Sure, um, so linda jump in if I miss anything, but I think the idea is that um mpe will continue to communicate about the The group through our membership So you would receive that as an mpe member through our communications But everyone who registered for this group and who's registered separately for the facebook group will also continue to receive Direct emails and other communication from linda and the core team about the webinars and other events like that so Everyone who signed up and is here today and is signed up online for the um kickoff event will get Email communications about the next webinar All right, because I'm not sure we've been Warned that uh, there was something going on. Um, I've got the chance that uh Vassong Made it clear to us, but I'm not sure we did get something through mpe Okay, because we would have left it I mean it's in our newsletter and on our social media, but if it's helpful We can always email you directly with updates on our programs and things like that. Whatever the best way Is to communicate. We're happy to do that. Um with our members because I know things can There's a lot going on so sometimes it's easy to miss things Okay But if that would be helpful linda can email you directly so that you can share that with your members Thank you any other question or remark and who There's someone from the uh, the group the core group want to say something before I think you were very clear in your presentation. Currently I just would like to add something for all of you for in europe in europe, uh, um, that Dr. François as menier Next week we'll have uh Next week. Yes next week. We'll have a session in um in brussels On discrimination against cancer survivors. So this means, you know, when you want to have as you said at the very beginning If you want to have a loan for a new house, you're young you you are You have cancer. Well, she's fighting for that and Several countries already in europe have Have signed so that you are not Discriminated by the banks to get a loan and this is very very important as Especially for young people and that's going to take place next week on the fifth on the 15th. If I remember well So, uh, and that's concerning europe Yeah 15th next week If you want if you want to have the information I can I can send them to you Thank you. It's the right to be forgotten Absolutely absolutely And she was the ceo. She's been the ceo for the um urtc for many many years Good, I think that's a couple of of of people Um Added some some topics uh elements on on the chat. Thank you for that. We we we definitely will add to uh to the list, of course Uh and meantime, I I see that we posted the uh the poll on on the facebook group as well um so I'll leave it to a couple of extra seconds Just to be sure that if someone has a question or before the closing uh closing of the call No further question Okay, let me a name of of european young malama patient and mp Let me thank you all for a time. Uh, it was um It was great to see that a lot of people were uh have been joining. Um, I have to say I wouldn't expect so many of you so I'm I'm really I'm really happy if if we may be happy in this Circumstances, but it means that that it means something for you. Uh, and uh, that it means that that that's that we uh Which we've chosen the right path to uh to uh try supporting you. Uh, you all so please Stay tuned. You will get uh very soon news from us for the first sessions, which means which apparently will be around nutrition We will see if if the uh if the poll will be changing on on on the facebook, but as we have, uh, Yeah, in 2025 a vote uh voting participants We see that nutrition seems to be very important to uh to you all So, of course, we'll try to find the best the best And I think I have already an idea on who could potentially be An ick doing I think we we are thinking about the same the same person. So Definitely we we already have someone who could help us all to uh to have the right the right pitch to uh to to help your nutrition. So We'll leave you 10 minutes uh extra. So a warm warm thank you. Uh, and again, uh, welcome in uh in our group and uh Stay uh, stay uh Stay in touch. Uh, we will come back on you and um very very soon And uh, keep strong. Thank you